Healthcare -
Biotechnology - NASDAQ - US
$ 19.07
-7.43 %
$ 3.24 B
Market Cap
-7.28
P/E
IMVT - NET INCOME
Net Income IMVT - Immunovant, Inc.
-259 M
LAST VALUE
-28.63%
2 YEAR CAGR
-55.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR